Akatsuka T, Toyama T, Morimura S, Komuta M, Mori I, Tanaka T, Tabei Y, Kawashima M, Matsuno A, Sugaya M. A case of primary meningeal melanocytosis treated with combination therapy with nivolumab and ipilimumab. 2023. J Dermatol 50:e125-e126.
Norimatsu Y, Akatsuka T, Matsuoka A, Hamada T, Mori I, Shiomi T, Mori N, Onishi K, Togashi Y, Inoue N, Takeuchi K, Sugaya M. Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node. 2024. J Dermatol 2024. 51:120-124.
Norimatsu Y, Akatsuka T, Ito K, Matsuoka A, Honda R, Morimura S, Hamada T, Kaneda M, Nishizawa T, Sugaya M. Case report: Very early systemic sclerosis with anti-Sjögren's syndrome/scleroderma autoantigen 1 antibody accompanied by gastric antral vascular ectasia. 2024. Int J Rheum Dis 2024. 27:e15062.
Hirai Y, Asada H, Hamada T, Kawada JI, Kimura H, Arai A, Ohshima K, Ohga S, Iwatsuki K; Committee for Guidelines for the Management of Chronic Active EBV Disease and Related Disorders (the MHLW Research Team in Japan). Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy. 2023. J Dermatol 50:e198-e205.
Miyagaki T, Inoue N, Kamijo H, Boki H, Takahashi-Shishido N, Suga H, Shimauchi T, Kiyohara E, Hirai Y, Yonekura K, Takeuchi K, Sugaya M. Prognostic factors for primary cutaneous anaplastic large cell lymphoma: a multicenter retrospective study from Japan. 2023. Br J Dermatol 189:612-620.
Sunagawa K, Manabe K, Hamada T. Dermatofibrosarcoma protuberans coexisting with sarcoid reaction in a patient with sarcoidosis. 2023. J Dermatol 50:e194-e195.
Norimatsu Y , Yoshizaki A , Yamada T , Akiyama Y , Toyama S , Sato S. Pemphigus vulgaris with advanced hypopharyngeal and gastric cancer following SARS-CoV-2 vaccination. 2023. J Dermatol. 50(2):e74-e75.
Norimatsu Y, Matsuda KM, Yamaguch K, Ono I, Okumura T, Kogo E, Kotani H, Hisamoto T, Kuzumi A, Fukasawa T, Yoshizaki-Ogawa A, Goshima N, Sato S, Yoshizaki A. The Autoantibody Array Assay: A Novel Autoantibody Detection Method. 2023. Diagnostics 13(18): 2929.
Matsuda KM, Kotani H, Yamaguchi K, Okumura T, Fukuda E, Kono M, Hisamoto T, Kawanabe R, Norimatsu Y, Kuzumi A, Fukayama M, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Okamura T, Shoda H, Fujio K, Goshima N, Sato S, Yoshizaki A. Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening.2023 . J Autoimmun. 135:102995.
Fukasawa T, Yoshizaki A, Ebata S, Fukayama M, Kuzumi A, Norimatsu Y, Matsuda MK, Kotani H, Sumida H, Yoshizaki-Ogawa A, Kagebayashi H, Sato S. Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis: Analysis of a single-arm, open-label, phase 1 trial. 2023. J Am Acad Dermatol. 89(2):366-369.
Norimatsu Y, Matsuda MK, Yamaguchi K, Ono C, Okumura T, Kogo E, Kotani H, Hisamoto T, Kuzumi A, Fukasawa T, Yoshizaki-Ogawa A, Goshima N, Sato S, Yoshizaki A. The Autoantibody Array Assay: A Novel Autoantibody Detection Method. 2023. Diagnostics (Basel).13(18):2929.
Norimatsu Y, Goto T, Kogure A, Kuwano Y. Chemical burns generated by chlorine gas. 2023. JEADV Clin Pract. 2:341-342.
Kuzumi A, Norimatsu Y, Matsuda KM , Ono C , Okumura T , Kogo E , Goshima N , Fukasawa T , Fushida N , Horii M , Yamashita T , Yoshizaki-Ogawa A , Yamaguchi K , Matsushita T , Sato S , Yoshizaki A. Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. 2023. Front Immunol. 28(14):1255540.
FukasawaＴ,YamashitaＴ, Enomoto A , Norimatsu Y, Toyama S, Yoshizaki-Ogawa A,Tateishi S , Kanda H, Miyagawa K,Sato S, Yoshizaki A. The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis. 2023. Front Immunol 14:1286251.
